Efficacy and Safety of Androgen Receptor Pathway-Targeted Therapies in AR-Positive Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

An article created on 2026-10-20 15:22:18

#	Наименование новости	Информативность	Дата публикации
1	Resistance of breast cancer stem cells to TROP2-targeted CAR-T therapy via the NF-κB signaling pathway	29.05	20-10-2026
2	Sacubitril/Valsartan for Breast Cancer Therapy-Related Cardiac Dysfunction: An Integrated Meta-Analysis and Bioinformatics Study	23.93	20-10-2026
3	Endocrine toxicity associated with anti - neoplastic drugs: a pharmacovigilance analysis based on the FDA adverse event reporting system database	12.94	19-10-2026
4	Laparoscopic Versus Robot-Assisted Radical Prostatectomy: Outcomes for pT3-4N0-1M0 Prostate Cancer	28.75	20-10-2026
5	Research Hotspots and Trends of Natural Killer Cells in Breast Cancer Immunotherapy: A Bibliometric Analysis	14.76	20-10-2026
6	Time to Maximal Response of Trastuzumab Deruxtecan in Patients with HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study (TRACE)	5	15-07-2026
7	A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphoma	13.31	20-10-2026
8	A prospective study of cardiac biomarkers in monitoring cardiac arrhythmia in Non-Hodgkin's lymphoma chemotherapy	17.1	20-10-2026
9	Immune checkpoint inhibitor adverse events in colorectal cancer: a disproportionality analysis of FAERS with cross-database validation in JADER	17.17	19-10-2026
10	The Effect of Early Neutropenia on PFS with Ribociclib Treatment in Advanced Breast Cancer	13.78	10-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 29.15. Источник: www.researchsquare.com.

Найдите то, что Вас интересует